ECRM_1170x120_8-1-17

biopharmaceuticals

Preserving the impact of biopharmaceutical innovation

Preserving the impact of biopharmaceutical innovation

NEW YORK — Health care economists, health system leaders and policy makers have been talking seriously about measuring and paying for value in health care for more than a decade. Hospitals, clinics, pharmacies and practitioners across the country now are starting to move in that direction, incentivized since 2015 by Medicare’s adoption of alternative care